Evidence map›Paper›PMID 41044374›Full record

ArticleCommunications chemistry2025

Silver nanospirals via autoaccelerated oriented assembly.

Rok Mravljak, Aleksandra Kuljanin, Tina Skalar, Boštjan Genorio, Marjan Marinšek, Aleš Podgornik

Abstract read
In one paragraph

Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rok MravljakDepartment of Chemical Engineering and Technical Safety, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
Aleksandra KuljaninDepartment of Chemical Engineering and Technical Safety, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
Tina SkalarDepartment of Chemical Engineering and Technical Safety, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
Boštjan GenorioDepartment of Chemical Engineering and Technical Safety, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.ORCID http://orcid.org/0000-0002-0714-3472
Marjan MarinšekDepartment of Chemical Engineering and Technical Safety, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
Aleš PodgornikDepartment of Chemical Engineering and Technical Safety, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia. ales.podgornik@fkkt.uni-lj.si.ORCID http://orcid.org/0000-0001-7308-0222

Funding

The Slovenian Research and Innovation Agency (ARIS) infrastructure program No. I0-0022The Slovenian Research and Innovation Agency (ARIS) J2-50048The Slovenian Research and Innovation Agency (ARIS) P1-0153The Slovenian Research and Innovation Agency (ARIS) P1-0175The Slovenian Research and Innovation Agency (ARIS) P2-0423
6 · The paper itself

Abstract

The unusual geometry of spiral nanocrystals gives rise to unique optical, electronic, and mechanical properties. In addition, noble metal nanoparticles, such as gold and silver, exhibit strong plasmonic responses, making them highly attractive for applications in sensing, photonics, and biomedicine. Spiral growth of noble metals was demonstrated for gold already over 70 years ago, yet its formation mechanism remains elusive. Here, we extend spiral morphology to silver, with yields of over 90%, that likely originates from the stochastic mismatch of dendrite arms during planar autoaccelerated oriented assembly (AOA). Silver nanoplates (AgNpt) synthesized via H

Identifiers

PMID41044374
PMCPMC12494873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.